Autoradiographic distribution of [3H]sumatriptan-binding sites in post-mortem human brain

Cephalalgia

Volumn 16, Issue 5, 1996, Pages 317-322

  Pascual, J ^a,b   Del Arco, C ^a   Romon T ^a   Del Olmo, E ^a   Castro, E ^a   Pazos, A ^a  

^a UNIVERSITY OF CANTABRIA   (Spain)

^b HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

5HT(1D) receptor subtype; 5HT(1F) receptor subtype; 3H sumatriptan; Nucleus tractus solitarius; Nucleus trigeminalis caudalis; Quantitative autoradiography

Indexed keywords

SEROTONIN 1D RECEPTOR; SEROTONIN 1F RECEPTOR; SUMATRIPTAN; ANTIEMETIC AGENT; SEROTONIN AGONIST; SEROTONIN RECEPTOR;

ARTICLE; BLOOD BRAIN BARRIER; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MIGRAINE; SOLITARY TRACT NUCLEUS; ADULT; ANIMAL; BRAIN; BRAIN LEVEL; BRAIN MAPPING; CHEMISTRY; GUINEA PIG; HISTOLOGY; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; RAT; SPECIES DIFFERENCE; VOMITING;

ADULT; ANIMALS; ANTIEMETICS; BLOOD-BRAIN BARRIER; BRAIN; BRAIN CHEMISTRY; BRAIN MAPPING; GUINEA PIGS; HUMANS; MIDDLE AGED; MIGRAINE DISORDERS; RATS; RECEPTOR, SEROTONIN, 5-HT1D; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS; SOLITARY NUCLEUS; SPECIES SPECIFICITY; SUMATRIPTAN; VOMITING;

EID: 0029658532     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-2982.1996.1605317.x     Document Type: Article

References (29)

1. Plosker GL, McTavish D. Sumatriptan. A reappraisal of its pharmacology and therapeutic efficacy in the acute treatment of migraine and cluster headache. Drugs 1994;47:622-51
2. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PPA. International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 1994;46: 157-203
3. Boess FG, Martin IL. Molecular pharmacology of 5HT receptors. Neuropharmacology 1994;33:275-317
4. Zifa E, Fillion G. 5-Hydroxytryptamine receptors. Pharmacol Rev 1992;44:401-58
5. 1-like receptor agonist GR 43175. Cephalalgia 1989;9:Suppl 9:23-33
6. 1 receptor subtype coupled to the inhibition of adenylate cyclase. Proc Natl Acad Sci USA 1993;90:408-12
7. 1F receptor binding sites in the guinea-pig brain: an autoradiographic study. Naunyn Schmiedeberg's Arch Pharmacol 1995;352:263-75
8. 1F receptors. Eur J Pharmacol 1996;295:271-4
9. Humphrey PPA, Feniuk W. Mode of action of the anti-migraine drug sumatriptan. Trends Pharmacol Sci 1991;12:444-6
10. Moskowitz MA. Neurogenic versus vascular mechanisms of sumatriptan and ergot extravasation in dura matter: proposed action in vascular headaches. Trends Pharmacol Sci 1992;13:307-11
11. Kaube H, Hoskin KL, Goadsby PJ. Inhibition by sumatriptan of central trigeminal neurones only after blood-brain barrier disruption. Br J Pharmacol 1993;109:788-92
12. 3H]sumatriptan binding in cat brain stem and spinal cord. Eur J Pharmacol 1995;280:175-8
13. 3H-ultrofilm: application to multiple benzodiazepine receptors. Proc Natl Acad Sci USA 1982;87:59-73
14. 1D binding sites in human and guinea-pig brain using different radioligands. Mol Brain Res 1994;21:19-29
15. 1D receptors in the human brain using a new iodinated radioligand. Mol Brain Res 1982;13:175-9
16. 1D receptors in human brain: an autoradiographic study. Eur J Neurosci 1996;8:53-60
17. 1F receptor binding sites in the guinea-pig brain. Br J Pharmacol Proceedings Suppl 1995;114:364P
18. 1B recognition sites. Brain Res 1986;376:85-96
19. 1C sites. Neurosci Lett 1988;85:357-62
20. Olesen J, Friberg L, Olsen ST, Iversen HK, Lassen NA, Andersen AR, Karle A. Timing and topography of cerebral blood flow, aura, and headache during migraine attacks. Ann Neurol 1990;28:791-8
21. Woods RP, Jacoboni M, Mazziotta JC. Bilateral spreading cerebral hypoperfusion during spontaneous migraine headache. N Engl J Med 1994;331:1689-92
22. Carpenter DO. Neural mechanisms of emesis. Can J Physiol Pharmacol 1990;68:230-6
23. Nozaki K, Moskowitz MA, Boccalini P. CP-93, 129, sumatriptan, dihydroergotamine block c-fos expression within rat trigeminal nucleus caudalis caused by chemical stimulation of the meninges. Br J Pharmacol 1992;106:409-15
24. Moskowitz MA. The trigeminovascular system. In: Olesen J, Telft-Hansen P, Welch KMA, editors. The headaches. New York: Raven Press, 1993:97-104
25. Friberg L, Olesen J, Iversen HK, Sperling B. Migraine pain associated with middle cerebral artery dilatation: reversal by sumatriptan. Lancet 1991;338:13-7
26. Moskowitz MA. Neurogenic versus vascular mechanisms of sumatriptan and ergot extravasation in dura matter: proposed action in vascular headaches. Trends Pharmacol Sci 1992;13:307-11
27. Goasdby PJ, Edvinsson L. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol 1993;48-56
28. Skingle M, Birch PJ, Leighton GE, Humphrey PPA. Lack of antinociceptive activity of sumatriptan in rodents. Cephalalgia 1990;10:207-12
29. Ferrari MD, Saxena PR. Clinical and experimental effects of sumatriptan in humans. Trends Pharmacol Sci 1993;14: 129-33